Quercetin-3-Methyl Ether Induces Early Apoptosis to Overcome HRV1B Immune Evasion, Suppress Viral Replication, and Mitigate Inflammatory Pathogenesis
10.4062/biomolther.2024.204
- Author:
Jae-Hyoung SONG
1
;
Seo-Hyeon MUN
;
Sunil MISHRA
;
Seong-Ryeol KIM
;
Heejung YANG
;
Sun Shim CHOI
;
Min-Jung KIM
;
Dong-Yeop KIM
;
Sungchan CHO
;
Youngwook HAM
;
Hwa-Jung CHOI
;
Won-Jin BAEK
;
Yong Soo KWON
;
Jae-Hoon CHANG
;
Hyun-Jeong KO
Author Information
1. Department of Pharmacy, Kangwon National University, Chuncheon 24341, Republic of Korea
- Publication Type:Original Article
- From:Biomolecules & Therapeutics
2025;33(2):388-398
- CountryRepublic of Korea
- Language:English
-
Abstract:
Human rhinovirus (HRV) causes the common cold and exacerbates chronic respiratory diseases, such as asthma and chronic obstructive pulmonary disease. Despite its significant impact on public health, there are currently no approved vaccines or antiviral treatments for HRV infection. Apoptosis is the process through which cells eliminate themselves through the systematic activation of intrinsic death pathways in response to various stimuli. It plays an important role in viral infections and serves as a key immune defense mechanism in the interactions between viruses and the host. In the present study, we investigated the antiviral effects of quercetin-3-methyl ether, a flavonoid isolated from Serratula coronata, on human rhinovirus 1B (HRV1B). Quercetin-3-methyl ether significantly inhibited HRV1B replication in HeLa cells in a concentration-dependent manner, thereby reducing cytopathic effects and viral RNA levels. Time-course and time-of-addition analyses confirmed that quercetin-3-methyl ether exhibited antiviral activity during the early stages of viral infection, potentially targeting the replication and translation phases. Gene expression analysis using microarrays revealed that pro-apoptotic genes were upregulated in quercetin-3-methyl ether-treated cells, suggesting that quercetin-3-methyl ether enhances early apoptosis to counteract HRV1B-induced immune evasion. In vivo administration of quercetin-3-methyl ether to HRV1B-infected mice significantly reduced viral RNA levels and inflammatory cytokine production in the lung tissues. Our findings demonstrated the potential of quercetin-3-methyl ether as a novel antiviral agent against HRV1B, thereby providing a promising therapeutic strategy for the management of HRV1B infections and related complications.
